April 30, 2024 at 04:02PM Recognition and Use of a Standard for Uniform Blood and Blood Component Container Labels

We, FDA, Center for Biologics Evaluation and Research (CBER), are recognizing as acceptable for use by you, manufacturers of blood and blood components, subject to United States statutes and regulations, the document entitled “United States Industry Consensus Standard for the Uniform Labeling

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/dJU1Rmq